Risk factors and basic mechanisms of chronic thromboembolic pulmonary hypertension: a current understanding

Lang Irene M., Pesavento Raffaele, Bonderman Diana, Yuan Jason X-J.

Source: Eur Respir J 2013; 41: 462-468
Journal Issue: February
Disease area: Pulmonary vascular diseases

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Lang Irene M., Pesavento Raffaele, Bonderman Diana, Yuan Jason X-J.. Risk factors and basic mechanisms of chronic thromboembolic pulmonary hypertension: a current understanding. Eur Respir J 2013; 41: 462-468

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Risk factors for chronic thromboembolic pulmonary hypertension
Source: Eur Respir Rev 2012; 21: 27-31
Year: 2012



Chronic thromboembolic pulmonary hypertension
Source: Eur Respir Mon 2012; 57: 108-118
Year: 2012


Pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: pathophysiology
Source: Eur Respir Rev 2009; 19: 59-63
Year: 2010



Risk factors for chronic thromboembolic pulmonary hypertension
Source: Eur Respir J 2009; 33: 325-331
Year: 2009



Chronic thromboembolic pulmonary hypertension: role of medical therapy
Source: Eur Respir J 2013; 41: 985-990
Year: 2013



Managing chronic thromboembolic pulmonary hypertension: pharmacological treatment options
Source: Eur Respir Rev 2009; 18: 24-28
Year: 2009


A roadmap for management of chronic thromboembolic pulmonary hypertension
Source: Eur Respir J, 54 (4) 1901295; 10.1183/13993003.01295-2019
Year: 2019



Survival in pulmonary hypertension in Spain: insights from the Spanish registry},
Source: Eur Respir J 2012; 40: 596-603
Year: 2012



ERS statement on chronic thromboembolic pulmonary hypertension
Source: ERS webinar 2021: ERS statement on chronic thromboembolic pulmonary hypertension
Year: 2021


Chronic thromboembolic pulmonary hypertension: the evolving treatment landscape
Source: Eur Respir Rev 2015; 24: 173-177
Year: 2015


Chronic thromboembolic pulmonary hypertension: do we need a new definition?
Source: Eur Respir J 2014; 44: 1401-1403
Year: 2014


Chronic thromboembolic pulmonary hypertension in acute pulmonary embolism: A risk factor evaluation study
Source: Virtual Congress 2020 – Pulmonary embolism
Year: 2020


Chronic thromboembolic pulmonary hypertension
Source: Annual Congress 2007 - Update on venous thromboembolism
Year: 2007


Novel treatment for pulmonary vascular disease: lessons from pathophysiology
Source: Annual Congress 2006 - Molecular pathology: an approach to lung diseases
Year: 2006


The changing landscape of chronic thromboembolic pulmonary hypertension management
Source: Eur Respir Rev, 26 (146) 170105; 10.1183/16000617.0105-2017
Year: 2017



Microvascular disease in chronic thromboembolic pulmonary hypertension: the story continues
Source: Eur Respir J 2014; 44: 1121-1122
Year: 2014


Risk assessment in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
Source: Eur Respir J, 53 (6) 1802004; 10.1183/13993003.02004-2018
Year: 2019



Analysis of mortality risk factors in a population with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
Source: Annual Congress 2010 - Pulmonary hypertension
Year: 2010


Genetic diagnostics in patients with chronic thromboembolic pulmonary hypertension
Source: International Congress 2019 – Novel methods, diagnostics and biomarkers in chronic lung diseases
Year: 2019

Chronic thromboembolic pulmonary hypertension: animal models
Source: Eur Respir J 2013; 41: 1200-1206
Year: 2013